Compare CRL & TTMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRL | TTMI |
|---|---|---|
| Founded | 1947 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Electrical Products |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.8B | 12.0B |
| IPO Year | 1999 | 2000 |
| Metric | CRL | TTMI |
|---|---|---|
| Price | $297.71 | $120.15 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 4 |
| Target Price | ★ $198.27 | $127.25 |
| AVG Volume (30 Days) | 923.3K | ★ 3.3M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 211.11 |
| EPS | N/A | ★ 1.24 |
| Revenue | $1,857,601,000.00 | ★ $2,906,345,000.00 |
| Revenue This Year | N/A | $18.60 |
| Revenue Next Year | $3.04 | $16.91 |
| P/E Ratio | ★ N/A | $90.56 |
| Revenue Growth | 10.48 | ★ 18.98 |
| 52 Week Low | $144.26 | $42.69 |
| 52 Week High | $300.59 | $223.83 |
| Indicator | CRL | TTMI |
|---|---|---|
| Relative Strength Index (RSI) | 76.44 | 43.84 |
| Support Level | $149.72 | $87.36 |
| Resistance Level | N/A | $150.07 |
| Average True Range (ATR) | 9.71 | 7.80 |
| MACD | 0.64 | -0.69 |
| Stochastic Oscillator | 93.34 | 37.98 |
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
TTM Technologies Inc manufactures technology products, including mission systems, RF components, RF/microwave assemblies, and advanced interconnect products such as PCBs and substrates. It operates through three segments: A&D, Commercial, and RF&S Components. The A&D segment supports aerospace and defense missions with PCBs, assemblies, microelectronics, and integrated systems. The Commercial segment, generating the majority of revenue, serves automotive, medical, industrial, and data center markets. The RF&S Components segment provides TTM-designed RF components and COTS products. The Company's revenues come from PCBs, engineered systems, and long-term contracts for intelligence, surveillance, and communications solutions.